Mesenchymal stem cells transplantation for systemic lupus erythematosus.

about

Bone marrow-derived mesenchymal stem cells inhibit T follicular helper cell in lupus-prone mice.Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus.

P2860

Q39155259-7CE5E65A-839C-42EA-924B-7B0F7CB5A0DF Q54989352-BE227D7C-A44D-440D-8FB5-4260B4339DFD

P2860

Mesenchymal stem cells transplantation for systemic lupus erythematosus.

Item

http://www.wikidata.org/entity/Q38328472

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Mesenchymal stem cells transplantation for systemic lupus erythematosus.

@en

type

Item

label

Mesenchymal stem cells transplantation for systemic lupus erythematosus.

@en

prefLabel

Mesenchymal stem cells transplantation for systemic lupus erythematosus.

@en

P1476

Mesenchymal stem cells transplantation for systemic lupus erythematosus.

@en

P2093

Jun Liang

http://www.w3.org/2001/XMLSchema#string

Lingyun Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Human mesenchymal stem cells modulate allogeneic immune cell responses

Mesenchymal stem cells in health and disease

Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study

Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice

Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation

Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells

Mesenchymal stem cell treatment for autoimmune diseases: a critical review.

Mesenchymal stem cells for the treatment of systemic lupus erythematosus: is the cure for connective tissue diseases within connective tissue?

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.

Wharton's jelly-derived cells are a primitive stromal cell population.

P304

164-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1756-185X.12531

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25611801

http://www.w3.org/2001/XMLSchema#string

Mesenchymal stem cells transplantation for systemic lupus erythematosus.

about

P2860

P2860

Mesenchymal stem cells transplantation for systemic lupus erythematosus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698